HBV and HCV Therapy
One year of interferon therapy inhibits HBV replication in one third of the patients whereas long-term administration of oral nucleos(t)ide analogues is efficient in most of them, as long as early treatment adaptation in patients with partial virological response and resistance is provided. Followin...
| Hoofdauteurs: | , , , |
|---|---|
| Formaat: | Artikel |
| Taal: | English |
| Gepubliceerd in: |
MDPI AG
2009-10-01
|
| Reeks: | Viruses |
| Onderwerpen: | |
| Online toegang: | http://www.mdpi.com/1999-4915/1/3/484/ |